Skip to main content

Animations

MJFF Publications

7061 - 7070 of 8808 Results
Title
Year
  • Year
  • 2017
  • 2024
  • 2024
  • 2023
  • 2023
  • 2023
  • 2023
  • 2024
  • 2024
  • 2024
  • Summary Details
    OPEN
    Title: Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson's disease
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2017.03.012
    Citation Count: 64
  • Summary Details
    OPEN
    Title: SNPs in cytochromes P450 catalyzing cholesterol degradation in brain are associated with Parkinson’s disease
    Journal Name: Frontiers in Pharmacology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fphar.2024.1477009
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Impact of excessive daytime sleepiness on the progression of freezing of gait in de novo Parkinson’s disease: a cohort study
    Journal Name: Neurological Sciences
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s10072-024-07738-8
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Altered dynamic functional network connectivity in drug-naïve Parkinson’s disease patients with excessive daytime sleepiness
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2023.1282962
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Association of cardiovascular disease management drugs with Lewy body dementia: a case–control study
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcad346
    Citation Count: 5
  • Summary Details
    OPEN
    Title: A mitochondrial inside-out iron-calcium signal reveals drug targets for Parkinson’s disease
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.celrep.2023.113544
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Cerebrospinal fluid biomarkers profile in scans without evidence of dopaminergic deficits (SWEDD)
    Journal Name: IBRO Neuroscience Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.ibneur.2023.10.001
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Single-cell spatial transcriptomic and translatomic profiling of dopaminergic neurons in health, aging, and disease
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.celrep.2024.113784
    Citation Count: 8
  • Summary Details
    RESTRICTED
    Title: Evaluation of ATN PD Framework and Biofluid Markers to Predict Cognitive Decline in Early Parkinson Disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000208033
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Perspective Strategies for Interventions in Parkinsonism: Remedying the Neglected Role of TPPP
    Journal Name: Cells
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/cells13040338
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.